Reduction in Recruitment Time: By automating the identification of suitable candidates, the company reduced its recruitment time by 50%, allowing clinical trials to commence more quickly and efficiently.
Decrease in Screening Failures: The AI-driven platform accurately matched patient data to trial requirements, resulting in a 30% reduction in the number of ineligible participants who failed the screening process.
Increase in Enrollment Efficiency: The streamlined recruitment process and automated candidate identification improved the efficiency of enrolling participants, reducing the workload on trial coordinators by 20%
Business Challenge:
A large pharmaceutical company conducting multiple clinical trials faced challenges in identifying suitable candidates from a vast pool of patients. Traditional methods of recruiting participants relied on manual screening, which was time-consuming, inefficient, and often led to delays in trial commencement. Furthermore, many patients who joined trials were later found to be ineligible, leading to costly setbacks. The company needed a more efficient, data-driven approach to streamline the recruitment process, improve accuracy, and ensure that only eligible candidates were selected for the trials.
Solution:
Syntes AI implemented an AI-driven candidate identification platform designed to streamline the selection of suitable participants for clinical trials. The platform analyzed vast amounts of patient data, including medical history, demographics, treatment records, and genetic information, to match patients with the eligibility criteria of specific clinical trials. By using advanced machine learning algorithms, the system quickly identified candidates who were most likely to meet the trial requirements, reducing the burden on trial recruiters and minimizing the risk of ineligible candidates entering the trials.
Key Features for Clinical Trial and Research Teams:
Steps to Implement:
Summary:
Syntes AI’s AI-driven clinical trial candidate identification platform helps pharmaceutical companies and research institutions efficiently and accurately identify suitable participants for clinical trials. By leveraging machine learning to analyze patient data and match individuals to trial eligibility criteria, the platform reduces recruitment time, minimizes screening failures, and improves the overall quality of clinical trial participants. This solution is essential for organizations looking to accelerate their clinical trials, enhance participant selection, and achieve more reliable trial results.